Referring to Dr Tony Gianduzzo

Dr Gianduzzo provides specialist assessment of elevated or rising PSA and suspected early prostate cancer — diagnosis, risk stratification, and active surveillance. He does not perform surgical or focal treatment; where treatment is indicated, patients are referred on to an appropriate specialist.

Updated PSA testing guidelines

The 2025 Guidelines for the Early Detection of Prostate Cancer, approved by the NHMRC, have superseded the 2016 PSA testing guidelines. Key changes relevant to referral:

  • Baseline PSA is now recommended for all interested men from age 40 (previously discouraged this early)
  • Two-yearly testing is recommended for ages 50–69
  • Testing beyond 70 is now based on clinical assessment rather than a blanket recommendation against it
  • Earlier and more frequent testing (from age 40) is recommended for men at higher risk, including those with a family history of prostate cancer
  • Full guideline documentation, including the summary of recommendations, is available via the Prostate Cancer Foundation of Australia: PCFA — New guidelines for the early detection of prostate cancer →

Patient handout available for download:

What's considered a high PSA

As a general guide, a PSA over 3 ng/mL may be cause for concern. In men in their 40s, or with a family history of prostate cancer, this threshold is lower — over 2 ng/mL warrants consideration.

Avoid PSA testing within three months of an acute urinary tract infection — the result may be falsely elevated for a prolonged period and not useful for prostate cancer screening purposes.

When to refer, and useful tests beforehand

ELEVATED PSA: Please repeat the PSA at least 1 month after the initial test before referral where possible. If the repeat PSA falls, please still refer if the latest result remains above the desirable range. This helps confirm a persistent elevation and may support Medicare eligibility for MRI

Hard prostatic nodule: Please refer irrespective of PSA. Aggressive prostate cancers may present with a very low PSA

Please avoid ordering an MRI or urinary tract ultrasound prior to referral. Prostatic MRI is preferably organised by a urologist due to Medicare requirements and the complexity of interpretation — if an MRI has already been performed, please include the results with the referral. A urinary tract ultrasound is not required.

How to refer

Referrals are preferred via Medical Objects. Please include PSA history/trend, and DRE findings (if any). 

Urgent concerns

Dr Gianduzzo consults Mondays. If a situation genuinely can't wait, please phone the rooms and reception will do what they can to accommodate — for anything acute (e.g. urinary retention, suspected sepsis, cord compression), the appropriate pathway is the emergency department or on-call urology rather than this referral route.

After the referral is received

Referrals are typically triaged within 1–2 business days and actioned within 3 days. Reception will then contact the patient to arrange an appointment—by phone initially, followed by SMS or email if required.

Most patients are seen within 1–2 weeks of first contact, although this may be longer if repeat PSA testing is needed. If a second PSA is required prior to assessment, this will be arranged directly with the patient; referring GPs do not need to organise this separately.

Following the consultation, patients receive a plain-English summary of their discussion. This is generated with AI assistance and reviewed by Dr Gianduzzo prior to release. Many patients find this helpful for personal reference or for sharing with family members.

Keeping the GP informed

A letter is sent back to the referring GP, typically the same day as the consultation.

Find Dr Gianduzzo on HealthShare

Dr Gianduzzo's HealthShare profile is searchable directly from Best Practice and Medical Director. View profile on HealthShare →

Direct line for referrer queries

Reception: (07) 5444 0672